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Introduction {#sec1}
============

In contrast to the initiation and elongation stages of eukaryotic DNA replication, which have been studied intensively over recent decades ([@bib4], [@bib9], [@bib17]), very little is known about the process of DNA replication termination, which occurs whenever two replisomes from neighboring replication origins meet each other ([@bib19]). The final stages of DNA synthesis involve at least five processes that are particular to termination ([@bib19]): the convergence and encounter of the two replisomes, gap filling between the leading strand at one fork and the lagging strand of the other ([@bib20]), regulated disassembly of the replisome ([@bib21], [@bib44], [@bib45], [@bib49], [@bib67]), and decatenation of the sister chromatids that are the products of replication. The majority of these steps are understood very poorly, and almost nothing is known in any eukaryotic species about the mechanisms that drive fork convergence and replisome encounter.

During elongation, DNA unwinding by the replicative helicase causes torsional strain in the DNA template, which produces positive supercoils ahead of each replisome ([@bib36]). The removal of these supercoils by type I or II topoisomerases is essential for continued fork progression in both prokaryotes and eukaryotes ([@bib5], [@bib77], [@bib78]). When two forks converge, however, the remaining stretch of parental DNA becomes so short that supercoils cannot form ([@bib76]), and topoisomerases are sterically excluded ([@bib36]). Therefore, the final stages of DNA unwinding and DNA synthesis are thought to require clockwise rotation of the two converging replication forks to transfer the topological stress behind the two replisomes in the form of intertwines or precatenanes between the replicated sister chromatids ([@bib36], [@bib61]).

During DNA replication termination in the bacterium *E. coli* and the virus SV40, the removal of precatenanes by type II topoisomerases is essential for the converging replisomes to continue unwinding and complete DNA synthesis ([@bib30], [@bib32], [@bib56], [@bib65]). Moreover, the resolution of converged forks during termination of SV40 replication in human cells appears to be a slow process that leads to the accumulation of a "late replication intermediate" ([@bib62], [@bib70]). In contrast, however, type II topoisomerase activity is dispensable for the convergence of eukaryotic replisomes in budding yeast cells ([@bib3]) and in *Xenopus* egg extracts ([@bib20], [@bib42]). In addition, observations of DNA replication termination in *Xenopus* egg extracts indicated that two replisomes converge without detectable slowing or stalling ([@bib20]), in contrast to SV40 viral replication, despite the latter being dependent upon eukaryotic replication factors, apart from the viral DNA helicase T-antigen. Until now, the pathways supporting fork convergence in eukaryotes have remained enigmatic.

Here we analyze eukaryotic DNA replication termination *in vitro* using a reconstituted system based on purified budding yeast proteins that has been shown previously to support the initiation and elongation stages of chromosome duplication ([@bib18], [@bib78], [@bib79]). Our data identify a eukaryotic pathway for fork convergence that is mediated by Pif1-family DNA helicases and is independent of type II topoisomerase activity. Moreover, these findings lay the foundations for future studies of the mechanisms and regulation that govern DNA replication termination in eukaryotes.

Results {#sec2}
=======

Converging Replisomes Stall in the Absence of Accessory DNA Helicases {#sec2.1}
---------------------------------------------------------------------

Previous work ([@bib78]) established the minimal set of budding yeast proteins that is required *in vitro* to establish bi-directional forks from an origin of DNA replication on a circular plasmid template. In this system, the Mcm2-7 proteins (MCM \[minichromosome maintenance\]) that represent the catalytic core of the replicative helicase are first loaded as double hexamers onto double stranded DNA (dsDNA) at origins of replication and then activated in a separate step to form two CMG (Cdc45-MCM-GINS) helicases. A "minimal replisome" then assembles around CMG at each nascent DNA replication fork, with DNA polymerase α making primers for lagging-strand synthesis, whereas DNA polymerase ε extends the leading strand, and the type II topoisomerase Top2 removes supercoils to allow fork progression.

Further development of this reconstituted replication system ([@bib79]) added components of the replisome progression complex that assembles around the yeast CMG helicase ([@bib28]), including the type I topoisomerase Top1, and also added DNA polymerase δ (Pol δ) and other factors that are required for lagging-strand synthesis. Under these conditions, the two replisomes move away from the origin at similar rates as those seen *in vivo* ([@bib79]). Analogous to the situation at cellular replication forks, DNA polymerase α initiates every new DNA molecule, DNA polymerase ε (Pol ε) extends the leading strands, and Pol δ synthesizes each Okazaki fragment during lagging-strand synthesis ([@bib79]).

As a first step toward addressing whether the reconstituted replisomes are able to support the completion of plasmid replication when two forks converge, we monitored nascent strand formation in reactions containing the flap endonuclease Fen1 and the DNA ligase Cdc9, which are required for Okazaki fragment processing and nascent strand ligation. Using a 3.2-kb plasmid template ([Figures 1](#fig1){ref-type="fig"}A and [S1](#mmc1){ref-type="supplementary-material"}A; pBS/ARS1WTA), we observed the generation of approximately full-length nascent DNA in denaturing agarose gels, dependent on the presence of both Fen1 and ligase ([Figures 1](#fig1){ref-type="fig"}B and 1C; the replication reactions contained all of the factors indicated in [Figures S1](#mmc1){ref-type="supplementary-material"}B and S1C), indicating that the reconstituted replisomes traverse the majority of the plasmid template.Figure 1Converging Replisomes Stall in the Absence of Accessory DNA Helicases(A) A 3,189-bp plasmid template (pBS/ARS1WTA) and the products of complete DNA replication (left) or a defect in DNA replication termination (right).(B) Purified *S. cerevisiae* Cdc9 (ligase) and Fen1 were visualized by SDS-PAGE and Coomassie staining.(C) A 3,189-bp plasmid template (pBS/ARS1WTA) was replicated according to the schematic in [Figure S1](#mmc1){ref-type="supplementary-material"}B, and Fen1 and Cdc9 were included as indicated. Subsequently, the replication products were resolved in a denaturing agarose gel, and the radiolabeled nascent strands were detected by autoradiography.(D) The products of replicating the 3,189-bp plasmid in the presence of Fen1 and ligase were analyzed in a denaturing agarose gel alongside the indicated markers.(E) Similar reactions as those in (C) were performed in the absence of Top2 (to avoid catenation of replication products under these conditions), digested with SbfI as indicated, and then analyzed by native agarose gel electrophoresis (top). Shown at the bottom is the same gel stained with ethidium bromide to illustrate the efficiency of digestion by SbfI. The percentage of full-length products was determined by autoradiography, as described in [STAR Methods](#sec4){ref-type="sec"}. LRI, late replication intermediate.(F) A 9.7-kb plasmid template (pZN3) was replicated for 2 h and 50 min in the presence of ^32^P-dCTP (deoxycytidine triphosphate) before addition of a chase of cold dNTPs (see [STAR Methods](#sec4){ref-type="sec"} for details). Ligase and Fen1 were omitted from the reactions so that unligated leading strands could be monitored in denaturing agarose gels (bottom; we also omitted Pol δ from these reactions). In parallel, aliquots of the same samples were digested with SmaI and monitored in a native gel (top), revealing the accumulation of LRIs at the end of the reaction.See also [Figure S1](#mmc1){ref-type="supplementary-material"}.

Subsequently, however, a more careful analysis indicated that the ligated nascent strands were in fact between 3,000 and 3,100 nt in size ([Figure 1](#fig1){ref-type="fig"}D) and were thus about 90--190 nt shorter than the full-length plasmid. These data suggested that the majority of converging replisomes stall during the final stages of DNA replication in the reconstituted system. To explore this further, we resolved the products of similar reactions in native agarose gels. Digestion of complete replication products would produce 3.2-kb linear dsDNA ([Figure 1](#fig1){ref-type="fig"}A; Complete Replication). However, the vast majority of the digested reaction products migrated in a native gel as replication intermediates of approximately twice the plasmid size ([Figure 1](#fig1){ref-type="fig"}E; +SbfI), indicating that the replicated plasmids were still linked by a short stretch of parental dsDNA ([Figure 1](#fig1){ref-type="fig"}A, Termination defect).

Pulse-chase experiments demonstrated that the appearance of these large products was coincident with the generation of leading strands of approximately half unit length ([Figure 1](#fig1){ref-type="fig"}F; note that ligase and Fen1 were omitted in this case so that leading-strand synthesis could be monitored in denaturing gels). Overall, therefore, these data indicated that the reaction products represented late replication intermediates (LRIs), which result from stalling of converging replisomes before the final stretch of parental duplex DNA has been unwound.

LRI formation was independent of vector size or sequence ([Figures S1](#mmc1){ref-type="supplementary-material"}A and S1D) and was observed over a range of salt concentrations ([Figure S1](#mmc1){ref-type="supplementary-material"}E). In addition, the LRIs persisted in longer time course experiments ([Figure S1](#mmc1){ref-type="supplementary-material"}F), indicating that they are a terminal product of the replication reaction under these conditions. Because the replisome contains multiple factors that modulate fork progression, such as Mrc1-Tof1-Csm3 ([@bib11], [@bib72], [@bib74], [@bib79]), we also performed reactions with a "minimal" replisome that lacks these factors, at the same time omitting Pol δ and other proteins that are required for complete lagging-strand synthesis ([@bib78]). Again, however, the large majority of converging forks arrested, producing LRIs ([Figure S1](#mmc1){ref-type="supplementary-material"}G). These data indicated that LRI formation is an inherent consequence of fork convergence in the reconstituted replication system.

LRI Formation Does Not Reflect the Encounter of Converging Replisomes with Inactive Mcm2-7 Double Hexamers {#sec2.2}
----------------------------------------------------------------------------------------------------------

Although yeast plasmids are replicated from a single replication origin *in vivo*, Mcm2-7 double hexamers can also be loaded at additional sites during reconstituted reactions with naked DNA templates ([@bib55]) because of the presence of additional "cryptic" binding sites for the origin recognition complex (or ORC) ([@bib15]), which are normally suppressed by chromatin ([@bib1], [@bib18], [@bib38]). This raised the possibility that the two replisomes from one origin might encounter inactive Mcm2-7 double hexamers elsewhere on the plasmid during the course of elongation in our reconstituted replication reactions. Because the inactive Mcm2-7 complexes can slide along dsDNA ([@bib23], [@bib29], [@bib55]), it was conceivable that the double hexamers might be pushed ahead of the two replisomes and form a barrier to fork convergence during DNA replication termination, producing the LRIs. At present, the mechanism by which active forks lead to the displacement of inactive Mcm2-7 double hexamers is not understood.

As a first way of addressing whether an excess of loaded Mcm2-7 complexes contributes to LRI formation, we generated a chromatinized version of the 3.2-kb plasmid template used above ([Figure S2](#mmc1){ref-type="supplementary-material"}A). After loading the Mcm2-7 proteins onto DNA, replication reactions were performed in the presence or absence of the histone chaperone FACT (facilitates chromatin transactions), which is part of the replisome that assembles around the CMG helicase at replication forks ([@bib25], [@bib28]). As seen previously ([@bib38]), the replication of naked plasmid DNA was independent of FACT ([Figure 2](#fig2){ref-type="fig"}A, lanes 1 and 3), but fork progression through chromatin was impeded in the absence of FACT, producing a broad smear of replication intermediates ([Figure 2](#fig2){ref-type="fig"}A, lane 2). Importantly, the products of chromatin replication in the presence of FACT were indistinguishable from those seen upon replication of naked DNA, with the majority comprising LRIs ([Figure 2](#fig2){ref-type="fig"}A, lane 4). These findings indicated that the defect in fork convergence is still observed when Mcm2-7 loading is restricted to *ARS1* by chromatin assembly.Figure 2LRI Formation on Plasmids with a Single Origin of Replication(A) After replication of naked (lanes 1 and 3) or chromatinized (lanes 2 and 4) versions of a 3.2-kb plasmid, the products were digested with SpeI and analyzed in a native agarose gel. Chromatin templates were generated in the presence of ISWI1, Nap1, and histones, and the histone chaperone FACT was included in the replication step as indicated. RIs = replication intermediates.(B) A 5.5-kb plasmid template was generated that contained the origin *ARS306* but in which other putative binding sites for ORC were mutated so that replication could only initiate from a single site (1). The plasmid was linearized with the indicated enzymes (2 and 3) so that the origin was located at either end of the linearized dsDNA, as indicated.(C) The DNA templates depicted in (B) were replicated and then analyzed by native agarose gel electrophoresis (sample 1 was digested with SmaI after purifying the replicated DNA to remove catenanes). Pol δ, ligase, and Fen1 were omitted from these reactions so that un-ligated leading strands could be analyzed in denaturing agarose gels ([Figure S2](#mmc1){ref-type="supplementary-material"}B) to monitor origin specificity.(D) The 3.2-kb plasmid template was replicated in the presence of the indicated concentrations of Cdt1-Mcm2-7 before DNA purification, digestion with SmaI, and analysis by native gel electrophoresis.See also [Figure S2](#mmc1){ref-type="supplementary-material"}.

In a second approach, we used plasmid templates in which the cryptic ORC binding sites were mutated (pZN3 and pVA18; [Figure S1](#mmc1){ref-type="supplementary-material"}A) so that replication initiates specifically from the origin *ARS306*, even in the absence of chromatin ([@bib73]). As above, LRIs still formed during DNA replication (pZN3 in [Figure 1](#fig1){ref-type="fig"}F; pVA18 in [Figure 2](#fig2){ref-type="fig"}C, lane 1). Moreover, LRI formation did not reflect an elongation defect under such conditions because the majority of replication products were full-length when the template was linearized close to the origin so that a single replication fork traversed almost the entire length of the plasmid ([Figures 2](#fig2){ref-type="fig"}B, 2C, and [S2](#mmc1){ref-type="supplementary-material"}B, samples 2 and 3).

Finally, we investigated the effect of modulating the Mcm2-7 loading conditions for the naked 3.2-kb plasmid template that contained cryptic ORC binding sites in addition to the origin *ARS1*. We varied the concentration of Cdt1 and the Mcm2-7 proteins in the MCM loading reaction because this has been shown to influence the number of Mcm2-7 double hexamers that are loaded onto the DNA template ([@bib22]). At the highest concentration used, we found that the proportion of full-length reaction products was reduced severalfold ([Figure 2](#fig2){ref-type="fig"}D, compare 200 nM and 40 nM Mcm2-7) so that almost all of the replicated molecules comprised LRIs. This suggests that an excess of loaded Mcm2-7 complexes can indeed interfere with DNA replication termination. However, LRIs still represented over 80% of the replication products when the concentration of Mcm2-7 was lowered dramatically, to levels that reduced the efficiency of replication and should only support loading of a single Mcm2-7 double hexamer ([Figure 2](#fig2){ref-type="fig"}D, 4 nM Mcm2-7).

Taken together, these findings indicate that LRIs do not result from the encounter of converging replication forks with Mcm2-7 double hexamers nor from a defect in elongation (because an individual fork can replicate the entire length of a linearized template DNA). Instead, LRIs are produced by an inherent problem that arises when two reconstituted replisomes converge during DNA replication termination.

LRI Formation on Linear DNA {#sec2.3}
---------------------------

We next examined whether the LRI was specifically produced by DNA replication termination on a circular plasmid or would also result from replisome convergence on a linearized template. Using the 9.7-kb origin-specific plasmid (pZN3; [Figure S1](#mmc1){ref-type="supplementary-material"}A), we pulse-labeled the two nascent replication forks for 4 min ([Figure 3](#fig3){ref-type="fig"}A). At that point, we added a cold "chase" of deoxyribonucleotide triphosphates (dNTPs) together with the SmaI restriction enzyme, which cleaves the template DNA extremely rapidly under these conditions ([Figure 3](#fig3){ref-type="fig"}B), proximal to the origin *ARS306* and, thus, behind the two active replication forks. The progression and convergence of the two forks were then monitored in native agarose gels. Although linearization of the template routinely led to an ∼10% increase in the abundance of full-length products ([Figure 3](#fig3){ref-type="fig"}C, compare lanes 6 and 7), the LRIs still represented around 80% of the products synthesized under these conditions ([Figure 3](#fig3){ref-type="fig"}C, lane 6). Therefore, even when two replisomes approach each other on linearized DNA, the majority still stall upon convergence.Figure 3LRI Formation on Linearized Templates(A) A 9.7-kb plasmid (pZN3) with a single site of Mcm2-7 loading was replicated for 3 min and 50 s in the presence of ^32^P-dCTP to allow establishment of bi-directional replication forks. A chase of unlabeled dNTPs was then added, followed immediately by addition of SmaI to linearize the vector at the indicated site adjacent to the origin. Nascent DNA strands are shown in red. Note that Pol δ, ligase, and Fen1 were omitted in this experiment.(B) Control experiment illustrating that SmaI digestion of the 9.7-kb plasmid at 30°C in replication reaction buffer leads to linearization within 10 s. DNA was visualized with Sybr Safe stain.(C) The 9.7-kb plasmid template was linearized during replication as in (A), and samples were removed and quenched at the indicated times (lanes 1--6). As a control, undigested plasmid was replicated for 24 min in a parallel reaction (lane 7) before extraction of the replicated DNA and digestion with SmaI. The samples were then resolved in a native agarose gel and analyzed by autoradiography.

Eukaryotic Pif1-Family DNA Helicases Promote Fork Convergence {#sec2.4}
-------------------------------------------------------------

Although the convergence of two reconstituted replisomes produces a late replication intermediate, termination is extremely efficient when plasmid replication is initiated in yeast cell extracts ([@bib50]), and around 90% of the linearized reaction products comprise full-length dsDNA ([Figure 4](#fig4){ref-type="fig"}A). This suggests that efficient fork convergence relies on additional factors that are present in cells but absent from the purified replication system. Because the formation of LRIs indicates that the two converging replisomes cannot unwind the final stretch of parental dsDNA, we considered whether additional "accessory" DNA helicases might be important to stimulate DNA replication termination. Therefore, we expressed and purified a range of budding yeast DNA helicases that have diverse roles in chromosome duplication ([Figure 4](#fig4){ref-type="fig"}B) and incorporated them into the reconstituted replication reactions.Figure 4The Budding Yeast Pif1 and Rrm3 DNA Helicases Stimulate Fork Convergence *In Vitro*(A) Mcm2-7 double hexamers were loaded and phosphorylated on the 3.2-kb plasmid template, which was then replicated in extracts of early S phase yeast cells (see [STAR Methods](#sec4){ref-type="sec"} for details). The reaction products were purified and then digested with SbfI as indicated before analysis in a native agarose gel.(B) The indicated *S. cerevisiae* DNA helicases were purified and then visualized by SDS-PAGE and Coomassie staining. The asterisk denotes a contaminant in the Dna2 sample.(C) The indicated DNA helicases (see [STAR Methods](#sec4){ref-type="sec"} for concentrations) were included in replication reactions with the 3.2-kb plasmid template. The reactions were stopped and quenched after 20 min, and then the replicated products were purified and linearized with SpeI before resolution in a native agarose gel. Pol δ, Fen1, and ligase were omitted from the reactions to prevent strand displacement synthesis by Pol δ, which has been shown previously to be enhanced by Pif1-Rrm3 ([@bib51], [@bib57]). Sgs1-T-R, Sgs1-Top3-Rmi1.(D) The ability of the indicated enzymes to unwind a 25-bp DNA duplex, formed by annealing a 35-bp oligonucleotide to an M13 ssDNA template, was monitored as described in [STAR Methods](#sec4){ref-type="sec"}.(E) *Bacteroides* Pif1 was expressed and purified as described in [STAR Methods](#sec4){ref-type="sec"} and then visualized by SDS-PAGE and Coomassie staining (left). The 3.2-kb plasmid template was then replicated in the presence of 5 nM yeast Pif1 (*S.c.* \[*Saccharomyces cerevisiae*\]) or the indicated concentrations of *Bacteroides* Pif1 (*Bac*Pif1). The reaction products were purified, digested, and analyzed in native agarose gels.(F) The ability of the indicated concentrations of *Bac* Pif1 or *S.c.* Pif1 to unwind a 40-bp DNA duplex, formed by annealing a 55-bp oligonucleotide to an M13 ssDNA template, was monitored as above.See also [Figures S3](#mmc1){ref-type="supplementary-material"} and [S4](#mmc1){ref-type="supplementary-material"}.

Previous studies of DNA replication termination in *E. coli* showed that the RecQ helicase can unwind a late replication intermediate in the presence of Topoisomerase III and single-stranded DNA (ssDNA)-binding-protein, producing two daughter molecules that each have a short stretch of ssDNA ([@bib71]). The yeast RecQ ortholog Sgs1 associates with Top3 and another factor known as Rmi1. This complex plays an important role in resolving recombination intermediates, including Holliday junctions ([@bib7], [@bib41]), and can also catalyze the catenation and decatenation of dsDNA ([@bib12]; [Figure S3](#mmc1){ref-type="supplementary-material"}A). However, addition of Sgs1-Top3-Rmi1 to the replication reactions had no effect on LRI formation, indicating that the yeast RecQ helicase was unable to promote fork convergence under these conditions ([Figure 4](#fig4){ref-type="fig"}C; [Figures S3](#mmc1){ref-type="supplementary-material"}B and S3C; note that high concentrations of Sgs1-Top3-Rmi1 partially inhibited DNA replication in the reconstituted system). Similarly, the stalling of converging forks was unaffected by the presence of the anti-recombinase Srs2 ([@bib31]), the Dna2 nuclease-helicase that contributes to DNA repair and Okazaki fragment processing ([@bib69]), or the Chl1 helicase ([@bib47], [@bib60], [@bib64]) that plays an important but poorly defined role in the establishment of sister chromatid cohesion during chromosome duplication ([Figure 4](#fig4){ref-type="fig"}C; [Figures S3](#mmc1){ref-type="supplementary-material"}D--S3F). Importantly, the purified versions of Sgs1 (3′ to 5′), Srs2 (3′ to 5′), and Chl1 (5′ to 3′) were all active as DNA helicases *in vitro* ([Figure 4](#fig4){ref-type="fig"}D; purified Dna2 was active as a nuclease, which complicated analysis of its 5′ to 3′ helicase activity).

The budding yeast Pif1 and Rrm3 proteins are paralogs with 5′ to 3′ DNA helicase activity and partially overlapping functions during elongation. Pif1 and Rrm3 jointly help the replisome to bypass barriers at many sites around the genome, such as tRNA promoters, where non-nucleosomal proteins bind tightly to DNA ([@bib34], [@bib35], [@bib51], [@bib75]). Strikingly, addition of Pif1 to the reconstituted replication reactions greatly stimulated the formation of full-length dsDNA, with a corresponding reduction in the appearance of LRIs ([Figure 4](#fig4){ref-type="fig"}C; [Figure S3](#mmc1){ref-type="supplementary-material"}G). Moreover, Pif1 could also suppress LRI formation on chromatinized or linearized DNA templates ([Figures S4](#mmc1){ref-type="supplementary-material"}A and S4B). Similarly, the Rrm3 helicase also stimulated the formation of full-length molecules in analogous reactions ([Figure 4](#fig4){ref-type="fig"}C; [Figure S3](#mmc1){ref-type="supplementary-material"}H). However, a bacterial ortholog of Pif1-Rrm3 was much less effective at supporting fork convergence in the reconstituted yeast replication system ([Figure 4](#fig4){ref-type="fig"}E), even when added at a 10-fold higher concentration than yeast Pif1, despite being highly active as a DNA helicase ([Figure 4](#fig4){ref-type="fig"}F; note that *Bac* Pif1 is better able to unwind a 40-bp duplex than *S.c.* Pif1). These findings indicate that the budding yeast Pif1 and Rrm3 helicases have a specific ability to promote the convergence of yeast replisomes.

The addition of Pif1 and Rrm3 to the reconstituted replication reactions did not affect the rate of elongation ([Figure S5](#mmc1){ref-type="supplementary-material"}A), and replication was still dependent on the CMG helicase ([Figures S5](#mmc1){ref-type="supplementary-material"}B and S5C). To test directly whether the Pif1 and Rrm3 helicases can promote fork convergence, we examined the ability of wild-type or helicase-dead mutants of Pif1 and Rrm3 ([Figures 5](#fig5){ref-type="fig"}A and 5B) to resolve pre-formed LRIs. We generated LRIs as above in the absence of Pif1-Rrm3 and then added wild-type or mutant versions of Pif1 or Rrm3 together with a cold chase of unlabeled dNTPs. As shown in [Figures 5](#fig5){ref-type="fig"}C and 5D, both Pif1 and Rrm3 were able to resolve pre-formed LRIs and stimulate the production of full-length dsDNA, dependent on their helicase activity. Moreover, Pif1 could still unwind pre-formed LRIs in the presence of the DNA polymerase inhibitor aphidicolin ([Figure 5](#fig5){ref-type="fig"}E; Rrm3 was not tested in this assay) at doses that potently inhibited DNA synthesis in the reconstituted replication system ([Figure 5](#fig5){ref-type="fig"}F). In summary, these findings indicate that the Pif1 and Rrm3 helicases are able to support fork convergence during DNA replication termination by helping to unwind the final stretch of parental DNA. Furthermore, these data demonstrate that the LRIs are *bona fide* precursors for full-length replication products.Figure 5Pif1-Rrm3 Helicase Activity Supports LRI Resolution(A) Wild-type or ATP-binding mutants of Pif1 and Rrm3 were purified and then visualized by SDS-PAGE and Coomassie staining.(B) The ability of wild-type or helicase-dead versions of Rrm3 and Pif1 to unwind a 25-bp DNA duplex was monitored as in [Figure 4](#fig4){ref-type="fig"}.(C) LRIs were generated as above before addition of the indicated concentrations of wild-type PIf1 or a helicase-dead variant (Pif1-K264A) together with a cold chase of unlabeled dNTPs. The products were digested with SbfI before analysis in a native agarose gel.(D) Analogous reactions with wild-type Rrm3 or a helicase-dead equivalent (Rrm3-K260A). Products were digested with SpeI before native gel analysis.(E) The ability of Pif1 to unwind pre-formed LRIs was monitored in pulse-chase experiments as in (C) and (D) in the presence of DMSO or aphidicolin (10, 40, and 100 μg/mL) as indicated.(F) The effect of DMSO or aphidicolin (4, 10, and 40 μg/ mL) on DNA synthesis of a 5.5-kb template was monitored by denaturing agarose gel electrophoresis in reactions that lacked Pol δ, ligase, and Fen1.See also [Figure S5](#mmc1){ref-type="supplementary-material"}.

Pif1 and Rrm3 Support a Top2-Independent Pathway for DNA Replication Termination {#sec2.5}
--------------------------------------------------------------------------------

In *E.coli*, the type II topoisomerase TopoIV stimulates DNA replication termination by removing precatenanes behind the converging DNA replication forks, reducing torsional strain and allowing the final stages of DNA unwinding to proceed ([@bib30]). To investigate whether type II topoisomerases contribute to fork convergence in the reconstituted yeast replication system, we compared the ability of yeast Top1 or Top2 and *E. coli* TopoIV to promote DNA replication termination. In the absence of any topoisomerase, forks stalled during elongation ([Figure S6](#mmc1){ref-type="supplementary-material"}A, lane 1) because of the accumulation of positive supercoils in front of each replication fork ([@bib78]). Although all three of the tested topoisomerases were able to support fork progression during elongation, the majority of reaction products were LRIs in all cases ([Figure S6](#mmc1){ref-type="supplementary-material"}A, lanes 2--5). However, slightly more full-length molecules were produced in the presence of the type II topoisomerases Top2 or TopoIV ([Figures S6](#mmc1){ref-type="supplementary-material"}A, lanes 3--5, and [S6](#mmc1){ref-type="supplementary-material"}B) compared with a reaction containing the type I enzyme Top1 ([Figures S6](#mmc1){ref-type="supplementary-material"}A, lane 2, and [S6](#mmc1){ref-type="supplementary-material"}B). These findings indicate that type II topoisomerase activity has a modest ability, under these conditions, to promote fork convergence in the absence of Pif1-Rrm3.

To investigate whether Pif1-family helicases promote DNA replication termination independent of type II topoisomerase activity, we compared the ability of Pif1 to drive fork convergence in the presence of Top1, Top2, or both enzymes ([Figure 6](#fig6){ref-type="fig"}A). The stimulation of fork convergence by Pif1 was comparable in the presence of either Top1 or Top2 ([Figure 6](#fig6){ref-type="fig"}A; [Figure S6](#mmc1){ref-type="supplementary-material"}C), indicating that the action of a type II topoisomerase is not required for Pif1 to promote fork convergence. Nevertheless, the production of full-length products was reproducibly enhanced in reactions containing Pif1 together with both Top1 and Top2 ([Figures 6](#fig6){ref-type="fig"}A and [S6](#mmc1){ref-type="supplementary-material"}B).Figure 6Pif1-Family Helicases Support a Top2-Independent Pathway for DNA Replication Termination(A) The 3.2-kb plasmid template was replicated in the presence of the indicated topoisomerases with or without Pif1. The products were digested with SmaI before analysis in a native agarose gel.(B) Reaction schematic for experiments to test whether Pif1 and Rrm3 can support complete plasmid duplication in the absence of Top2. Reactions were performed in the presence of Pol δ, Fen1, ligase, and Top1 with or without Pif1-Rrm3. Complete plasmid replication would produce catenated dimers, which could then be purified and decatenated by *E. coli* TopoIV.(C) Reactions performed as in (B) were analyzed in native agarose gels in the absence of the DNA intercalator ethidium bromide.(D) The same reaction products were resolved in a native agarose gel in the presence of 0.5 μg/mL ethidium bromide.See also [Figure S6](#mmc1){ref-type="supplementary-material"}.

Finally, we tested whether Pif1 and Rrm3 can support the completion of DNA replication termination and the production of completely ligated products in the absence of type II topoisomerase activity (reactions containing Top1 but not Top2). If plasmid replication were complete under such conditions, then the products should represent catenated dimers, which could then be decatenated with *E. coli* TopoIV after purification of the replicated DNA ([Figure 6](#fig6){ref-type="fig"}B). This would produce relaxed monomers, into which negative supercoils could then be introduced by incubation with the DNA intercalator ethidium bromide. As shown in [Figure 6](#fig6){ref-type="fig"}C, decatenation of the products of reactions containing Pif1 or Rrm3 did indeed produce relaxed monomers (note that the reaction products were not linearized in these experiments, in contrast to those above). Moreover, a proportion of the reaction products were converted into supercoiled monomers in the presence of ethidium bromide, indicating that the products comprised covalently closed circles ([Figure 6](#fig6){ref-type="fig"}D). Therefore, both Pif1 and Rrm3 are able to drive fork convergence and the completion of DNA synthesis in the complete absence of topoisomerase II activity.

Rrm3 and Pif1 Are Required for Efficient Termination of Plasmid Replication *In Vivo* {#sec2.6}
-------------------------------------------------------------------------------------

To explore the *in vivo* significance of the Pif1 helicase family for DNA replication termination, we used native agarose gels and Southern blotting to screen for the appearance of LRIs during plasmid replication in synchronized yeast cells. Previous work showed that LRIs accumulated transiently when fork convergence was impeded in budding yeast cells by expression of a catalytically dead form of Top2 ([@bib3]). Although LRIs were not observed during plasmid replication in control cells, they accumulated strikingly in *rrm3Δ pif1-m2* double mutant cells before being resolved at later time points ([Figures 7](#fig7){ref-type="fig"}A and 7B; note that *rrm3Δ pif1Δ* cells were too sick to examine in similar experiments, and so we used the *pif1-m2* allele, which expresses the mitochondrial isoform of the protein but lacks nuclear Pif1). In contrast, LRI accumulation was less severe in *rrm3Δ* and absent in *pif1Δ* single mutant cells ([Figure S7](#mmc1){ref-type="supplementary-material"}A), indicating that the Rrm3 and Pif1 DNA helicases play a partially redundant role in promoting fork convergence during DNA replication termination in budding yeast cells.Figure 7Pif1-Rrm3 Are Required for Efficient Termination of Plasmid DNA Replication *In Vivo*(A) Control (W303-1a) and *pif1-m2 rrm3Δ* (yMO291) yeast strains containing the plasmid pRS425 were arrested in G1 phase with mating pheromone and then released into S phase for the indicated times. DNA content was monitored by flow cytometry.(B) Samples from each time point were used to prepare total DNA, which was then analyzed by native agarose gel electrophoresis and Southern blotting ([@bib8]). The positions of various plasmid isoforms are indicated, and the red arrow indicates the accumulation of LRIs in *pif1-m2 rrm3Δ* cells.(C) The DNA samples from the 40-min time point in (B) were digested at the origin of replication with SnaBI before resolution in a two-dimensional neutral-neutral agarose gel, as described in [STAR Methods](#sec4){ref-type="sec"}. Left: the positions of linear molecules (black dot, bottom right) and replication intermediates (double Y structures of increasing size, located along the line from the linear dot to the LRI).See also [Figure S7](#mmc1){ref-type="supplementary-material"}.

To confirm that the LRIs observed in yeast cells lacking Pif1 and Rrm3 were caused by a specific defect in fork convergence during DNA replication termination rather than being produced by the pausing of forks at replication fork barriers, we explored the nature of the LRI by native-native two-dimensional gel electrophoresis. DNA isolated from the 40-min time point in the experiment in [Figure 7](#fig7){ref-type="fig"}B was digested with a restriction enzyme that cuts within the origin ([Figure S7](#mmc1){ref-type="supplementary-material"}B), and the samples were then analyzed by native-native two-dimensional gel electrophoresis. If cells lacking Pif1 and Rrm3 have a specific defect in fork convergence during termination, then the digested LRI should comprise a large "double Y" structure that approximates an X-shaped molecule with arms of roughly equal length (LRI in [Figure 7](#fig7){ref-type="fig"}C, left, and [Figure S7](#mmc1){ref-type="supplementary-material"}B). However, if the LRI is formed by one fork stalling at a barrier during elongation until the arrival of the second fork, then the digestion of the plasmid at the origin would produce an X-shaped LRI with uneven arm length, which would migrate further down the "X arc" in the two-dimensional gel ([Figure 7](#fig7){ref-type="fig"}C, left, black dotted line). In contrast to plasmid DNA from control cells ([Figure 7](#fig7){ref-type="fig"}C, center), the digested DNA sample from *pif1-m2 rrm3Δ* cells contained a single LRI species that migrated as a very large double Y near the top of the X arc ([Figure 7](#fig7){ref-type="fig"}C, right). This demonstrates that the LRI was produced by a defect in fork convergence on the opposite side of the plasmid to the origin.

Discussion {#sec3}
==========

We reconstituted the final stages of eukaryotic DNA replication and found that the majority of converging replisomes stall when CMG is the only DNA helicase in the reaction, producing late replication intermediates in which the ligated nascent strands are 90--190 bp shorter than the full-length plasmid ([Figure 1](#fig1){ref-type="fig"}D). The deficit in nascent strand size reflects the ∼30-bp footprint of the CMG helicase at each fork ([@bib54]), together with any parental dsDNA between the converged replisomes, and also the gap between the 5′ end of the lagging strand and the 3′ end of the leading strand at each fork ([Figure 1](#fig1){ref-type="fig"}A). The observed difference between the size of ligated nascent strands and the full-length plasmid is comparable with the situation when two replisomes converge at an inter-strand DNA cross-link in *Xenopus* egg extracts ([@bib54]). Therefore, the reconstituted yeast replisomes must be very close to each other in the LRI, and the remaining amount of parental dsDNA must be less than the minimal value of about ∼150 bp that is needed to form a loop or supercoil ([@bib76]). This implies that the converging replisomes stall after the point at which fork progression becomes dependent on replisome rotation and precatenane formation.

The defect in fork convergence is seen in the presence of type I or II topoisomerases, regardless of whether the reactions involve "minimal" ([@bib78]) or "complete" ([@bib79]) versions of the replisome or whether fork convergence occurs on circular or linearized DNA templates ([Figure 3](#fig3){ref-type="fig"}). Several potential explanations for LRI formation could be envisaged. First, the two replisomes might clash when they encounter each other. However, previous work indicated that the CMG helicase encircles the template of the leading strand and can bypass protein barriers on the lagging strand ([@bib27], [@bib40]). Furthermore, recent evidence indicates that the activation of an Mcm2-7 double hexamer during initiation produces two "converged" CMG helicases that must bypass each other before leaving the origin and establishing bi-directional replication forks ([@bib22]). This suggests that two converging replisomes should also be able to pass each other unimpeded during DNA replication termination.

A second potential explanation for LRI formation was that inactive Mcm2-7 double hexamers might block the convergence of two replisomes in the absence of factors (potentially including Pif1-Rrm3) that help forks to displace such "pre-replicative" complexes. However, LRIs are still seen under conditions where only a single double hexamer is loaded per plasmid, and our data indicate that the major defect in fork convergence in the reconstituted replication systems arises for another reason, although our findings do not exclude that inactive Mcm2-7 double hexamers have the potential to block progression of the CMG helicase.

A further possibility is that converging CMG helicases become arrested at a stage when continued replisome rotation is impaired by torsional strain. During DNA replication termination in *E. coli* and SV40, the removal of precatenanes by type II topoisomerases relieves torsional strain at converging forks and allows continued replisome rotation and completion of DNA unwinding. We note that Top2 does make a minor contribution to the efficiency of fork convergence in the reconstituted yeast replication system ([Figure S6](#mmc1){ref-type="supplementary-material"}), but depletion of type II topoisomerase does not block fork convergence in yeast cells ([@bib3]) or *Xenopus* egg extracts ([@bib20]). This indicates that eukaryotic cells have other pathways that can drive fork convergence during DNA replication termination, independent of type II topoisomerase activity. Our data identify one such pathway that is driven by the Pif1 helicase family and is distinct from the previously described prokaryotic mechanism of fork convergence.

The CMG helicase is essential for replisome progression and can unwind the DNA template over many kilobases, aided by stable entrapment of the leading-strand DNA template within the hexameric Mcm2-7 ring. In contrast, Pif1 and Rrm3 are monomeric DNA helicases that have low processivity ([@bib10], [@bib63]) and play important roles at specific points during elongation, unwinding highly stable structures, such as G4 quadruplexes, that might otherwise present a barrier to CMG ([@bib53], [@bib52]), and assisting with the replication of centromeres ([@bib13]). It is possible that the robust helicase activity of Pif1-Rrm3 helps to overcome torsional strain at converging forks, driving replisome rotation and helping to unwind the final stretch of parental dsDNA.

The polarity of Pif1 helicases is likely to be an important determinant of their ability to assist with DNA unwinding at converging replication forks. Both Pif1 and Rrm3 unwind DNA 5′ to 3′ and, thus, interact with the template of the lagging strand, complementing the 3′ to 5′ action of the CMG helicase along the leading-strand template. Notably, a bacterial Pif1 helicase was very inefficient at LRI resolution despite being a highly active DNA helicase *in vitro* ([Figures 4](#fig4){ref-type="fig"}E and 4F). Moreover, the Chl1 5′ to 3′ helicase was also unable to promote fork convergence in the reconstituted system ([Figures 4](#fig4){ref-type="fig"}C and 4D). These findings indicate that the budding yeast Pif1 helicases have a specific ability to support DNA replication termination, perhaps aided by a direct interaction with the budding yeast replisome. Consistent with this view, Rrm3 was found to interact with the catalytic subunit of Pol ε ([@bib2]).

In agreement with our *in vitro* data, Pif1 and Rrm3 share a partially overlapping role during the termination of plasmid replication in budding yeast cells, leading to the accumulation of LRIs in *rrm3Δ pif1-m2* cells ([Figure 7](#fig7){ref-type="fig"}; [Figure S7](#mmc1){ref-type="supplementary-material"}). Fork convergence is delayed but not abolished under such conditions, indicating that additional pathways contribute to termination *in vivo*, possibly including the removal of precatenanes by type II topoisomerases ([@bib24]). The existence of multiple pathways that promote fork convergence likely explains why budding yeast cells lacking both Pif1 and Rrm3 are very sick but able to form colonies. Functional redundancy with other fork convergence pathways might also explain the viability of mice that lack the single mammalian ortholog of Pif1 ([@bib66]). However, we cannot exclude that a penetrant defect in fork convergence in the absence of Pif1 helicases is counterbalanced by other pathways that can resolve X-shaped DNA molecules before cell division; for example, through the action of nucleases and recombination factors.

We note that our data are consistent with past studies that monitored fork convergence at protein-DNA barriers *in vivo* and that observed termination defects in budding yeast cells lacking Rrm3 ([@bib33], [@bib48]) or in fission yeast cells lacking the Pfh1 ortholog of Pif1-Rrm3 ([@bib59], [@bib68]). However, our findings establish that Pif1 and Rrm3 have a direct role in fork convergence per se rather than simply being required to remove a protein-DNA barrier that otherwise would block fork convergence.

The reconstitution of Pif1-dependent DNA replication termination sets the scene for future mechanistic studies of this enigmatic and fascinating area of chromosome duplication. It will be particularly interesting to determine how the termination of DNA synthesis provides a signal for disassembly of the eukaryotic replisome, which is initiated by ubiquitylation of the CMG helicase and represents the final regulated step in eukaryotic chromosome replication ([@bib20], [@bib21], [@bib44], [@bib49], [@bib67]).

STAR★Methods {#sec4}
============

Key Resources Table {#sec4.1}
-------------------

REAGENT or RESOURCESOURCEIDENTIFIER**Antibodies**Anti-fluorescein-AP Fab fragmentsRoche000000011426338910**Bacterial and Virus Strains***Escherichia coli:* Rosetta (DE3) pLysS cells: F^−^*ompT hsdS*~B~(r~B~^−^ m~B~^−^) *gal dcm* (DE3) pLysSRARE (Cam^R^)Novagen70956**Chemicals, Peptides, and Recombinant Proteins**Anti-FLAG M2 affinity gelSigma-AldrichA2220Glutathione Sepharose 4BGE Healthcare17075601Ni-NTA agaroseQIAGEN30210Calmodulin Sepharose 4BGE Healthcare17052901Streptactin superflow resinIBA Life Sciences2-1206-002IgG Sepharose 6 Fast FlowGE Healthcare170969013Flag peptideSigma-AldrichF4799Roche Complete EDTA-free protease inhibitor cocktailRoche000000011873580001Sigma protease inhibitor cocktailSigma-AldrichP8215**Critical Commercial Assays**CDP-StarGE HealthcareGERPN3682Recombinant proteins are detailed in [Table S4](#mmc1){ref-type="supplementary-material"}**Experimental Models: Cell Lines**Sf21 insect cellsThermoFisher Scientific11497013**Experimental Models: Organisms/Strains***S. cerevisiae* strains are detailed in [Table S5](#mmc1){ref-type="supplementary-material"}**Recombinant DNA**pAM3 (Cdc6 purification)[@bib26]N/ApJY19 (PCNA purification)[@bib79]N/ApRJ1228-Nhp6 (Nhp6 purification)[@bib58]N/ApCDFduet.H2A-H2B (histones purification)[@bib37]N/ApCDFduet.H3-H4(histones purification)[@bib37]N/ApJFDJ5 (GINS purification)[@bib78]N/ApET28a-Mcm10 (Mcm10 purification)[@bib78]N/ApTF175 (FACT purification)[@bib6]N/ApJW22 (FACT purification)[@bib6]N/ApCFK1 (Nap1 purification)[@bib38]N/ApET11d-Srs2 (Srs2 purification)[@bib46]N/ApTDK10 (Pif1 purification)This studyN/ApTDK24 (Pif1 K264A purification)This studyN/ApTDK4 (generation of yTDK4 for Csm3-Tof1 purification)This studyN/ApTDK15 (generation of yTDK9 for Rrm3 purification)This studyN/ApTDK8 (generation of yTDK6 for Top1 purification)This studyN/ApTDK34 (generation of yTDK17 for Rrm3 K260A purification)This studyN/ApFV36 (generation of yFV43 for Dna2 purification)This studyN/ApTDK18 (generation of yTDK18 for Fen1 purification)This studyN/ApTDK19 (generation of yTDK19 for Cdc9 purification)This studyN/ApTDK13 (template for generation of molecular weight markers)This studyN/ApBS/ARS1WTA (3.2 kb replication template)[@bib43]N/ApCFK1_WT (5.8 kb replication template)[@bib78]N/ApVA18 (5.5 kb replication template)Valentina AriaN/ApZN3 (9.7 kb replication template)[@bib73]N/ApRS425Baxter laboratoryN/Aλ DNA-HindIII Digest: molecular weight markersNew England BiolabsN3012SM13 ssDNANew England BiolabsN4040S**Software and Algorithms**ImageJNational Institute of Health<https://imagej.nih.gov/ij/>

Contact for Reagent and Resource Sharing {#sec4.2}
----------------------------------------

Further information and requests for resources and reagents should be directed to the Lead Contact, Karim Labib (<kpmlabib@dundee.ac.uk>).

Experimental Model and Subject Details {#sec4.3}
--------------------------------------

The *Saccharomyces cerevisiae* strain yJF1 (*MAT***a** *ade2-1 ura3-1 his3-11,15 trp1-1 leu2-3,112 can1-100 bar1Δ::hphNT pep4Δ::kanMX*) was transformed with linearized plasmids using standard genetic procedures to generate the protein expression strains, as detailed in the '[Key Resources Table](#sec4.1){ref-type="sec"}', [Table S1](#mmc1){ref-type="supplementary-material"} and [Table S5](#mmc1){ref-type="supplementary-material"}. The codon usage of the synthetic gene constructs that were used for the protein expression strains was optimized for high-level expression in *Saccharomyces cerevisiae* ([@bib78]).

For expression of proteins in *E. coli*, the corresponding plasmids (listed in the [Key Resources Table](#sec4.1){ref-type="sec"} and [Table S1](#mmc1){ref-type="supplementary-material"}) were transformed into Rosetta (DE3) pLysS cells (Novagen) (F^-^ *ompT hsdS*~B~(r~B~^-^ m~B~^-^) *gal dcm* (DE3) pLysSRARE (Cam^R^).

Method Details {#sec4.4}
--------------

### Yeast methods {#sec4.4.1}

For expression of proteins, the corresponding strains (see [Table S5](#mmc1){ref-type="supplementary-material"}) were grown at 30°C in YP + 2% raffinose to a density of 2--4 × 10^7^ cells / ml. For expression of Mrc1, Csm3-Tof1, Rrm3, Top1, Fen1 and Cdc9, the cells were arrested in G1-phase by incubation for 3 h with 200 ng / ml alpha factor mating pheromone (Pepceuticals). Protein expression was then induced by addition of galactose to 2% for 3 h at 30°C. RFC, Pol δ and Dna2 expression was induced in the same way, but in asynchronous cultures.

Following expression, cells were collected by centrifugation and washed once with lysis buffer (see purification protocols for details of buffers used) without protease inhibitors. The cell pellets were then resuspended in 0.3--0.4 volumes of lysis buffer + protease inhibitors (see purification protocols for details) and the resulting suspensions were frozen drop-wise in liquid nitrogen. The frozen cells were crushed in a freezer mill (SPEX CertiPrep 6850 Freezer/Mill) with 4 cycles of 2′ at a rate of 15. The resulting powders were stored at −80°C until required.

For the experiments in [Figure 7](#fig7){ref-type="fig"} and [Figure S7](#mmc1){ref-type="supplementary-material"}, cells containing the plasmid pRS425 were grown to early log phase at 30°C, in minimal media supplemented with 2% glucose but lacking leucine, before transfer to rich medium supplemented with 2% Glucose (YPD: 1% yeast extract, 2% peptone), supplemented with 40 μg / ml of adenine. The cells were then grown to mid-log phase and arrested in G1-phase by addition of 10 μg / ml alpha factor per hour, until 95% of cells were unbudded (typically 120'). Cells were then washed three times in YPD medium lacking alpha factor, before further incubation in YPD. 'Time 0' was designated as the time of the addition of the first wash to the pelleted cells. Samples were taken at the indicated time points and used to prepare genomic DNA (2x10^8^ cells were pelleted and frozen on dry ice) or to monitor DNA content by flow cytometry ([@bib39]).

### Protein purification buffers {#sec4.4.2}

Buffer A: 25 mM HEPES KOH pH 7.6, 10% glycerol, 0.02% NP-40-S, 1 mM DTTBuffer B: 25 mM Tris-Cl pH 7.2, 10% glycerol, 1 mM DTTBuffer C: 25 mM Tris-Cl pH 8.5, 10% glycerol, 0.02% NP-40-S, 1mM DTTBuffer D: 25 mM Tris-Cl pH 7.2, 10% glycerol, 0.02% NP-40-S, 1 mM DTTBuffer E: 25 mM HEPES KOH pH 7.6, 10% glycerol, 5 mM MgOAc, 1 mM DTTBuffer F: 50 mM HEPES KOH pH 7.6, 10% glycerol, 1 mM DTT, 0.02% NP-40

#### Homemade protease inhibitor cocktail {#sec4.4.2.1}

1 mM PMSF, 5 mM benzamidine HCl, 1 mM AEBSF, 1 μg/ml pepstatin A, 1 μg/ml aprotinin

One protease inhibitor tablet (Roche, 000000011873580001) was used per 25 mL of lysis buffer where indicated.

1 mL of Sigma protease inhibitor cocktail (Sigma-Aldrich, P8215) was used per 100 mL of lysis buffer where indicated.

### Protein purification {#sec4.4.3}

Yeast protein expression strains, and expression plasmids for protein purification from *Escherichia coli* are detailed in the [Key Resources Table](#sec4.1){ref-type="sec"}, [Table S1](#mmc1){ref-type="supplementary-material"} and [Table S5](#mmc1){ref-type="supplementary-material"}. Proteins purified in this study are listed in [Table S4](#mmc1){ref-type="supplementary-material"}. During extract preparation, thawed yeast cell powder was resuspended in 2-3 volumes of the initial lysis buffer in all cases. After affinity purification from yeast or bacterial cell lysates, the affinity resin was washed with at least 40 column volumes of wash buffer in all instances.

#### Cdc9 {#sec4.4.3.1}

Powder was thawed in buffer C / 0.2 M NaCl / protease inhibitors (Roche tablets + Sigma protease inhibitors + homemade cocktail). Insoluble material was removed by centrifugation (235,000 x g, 4°C, 1 h) and the supernatant was mixed with 2.5 mL anti-FLAG M2 affinity gel (Sigma-Aldrich) at 4°C for 90 min.

The resin was collected and washed with buffer C / 0.2 M NaCl. Cdc9 was eluted in 1 column volume of buffer C / 0.2 M NaCl / 0.5 mg / ml 3FLAG peptide, then 1 column volume of buffer C / 0.2 M NaCl / 0.25 mg / ml 3FLAG peptide.

The eluate fraction was diluted 2-fold in buffer C then loaded onto a 1 mL HiTrap Q column in buffer C / 0.1 M NaCl. Cdc9 was eluted with a 20 column-volume gradient from 0.1 -- 0.7 M NaCl in buffer C. Cdc9 containing fractions were pooled, dialysed versus buffer A / 0.2 M KOAc, snap frozen and stored at −80.

#### Chl1 {#sec4.4.3.2}

A 20 mL aliquot of P5 viral supernatant, expressing full-length Chl1 including an N-terminal 2HA-6His-2Strep tag (a kind gift from Martin Singleton) was added to 2.8 l SF21 insect cells at a cell density of 1 million cells / ml. The cells were grown at 27°C with shaking at 110 rpm for 48 h. The cells were then harvested by centrifugation at 2500 rpm for 15 min at 4°C in a JLA9.1000 rotor (Beckman). The cell pellets were washed once in PBS + 5 mM MgOAc, resuspended in 6 volumes 25 mM HEPES pH 7.6, 0.02% Tween-20, 10% glycerol, 1 mM EDTA, 1 mM EGTA, 15 mM KCl, 2 mM MgOAc, 0.4 mM PMSF, 2 mM 2-mercaptoethanol, Roche protease inhibitor tablets, then snap frozen in aliquots.

Subsequently, the frozen cell suspension was thawed at room temperature, left on ice for 10 min, then lysed in a dounce homogenizer (20x compressions). KCl was added to 0.3 M and the sample centrifuged at 40,000 x g for 30 min at 4°C in a JA30.5 rotor (Beckman). The soluble fraction was recovered and mixed with 3 mL Streptactin superflow resin (IBA Life Sciences) for 90 min at 4°C with rotation. The beads were collected in a disposable column and washed extensively in 50 mM Tris-HCl pH 8.5, 0.3 M NaCl, 10% Glycerol, 1 mM DTT, then Chl1 was eluted in 2 column-volumes of 50 mM Tris-HCl pH 8.5, 0.3 M NaCl, 10% Glycerol, 1 mM DTT, 2.5 mM desthiobiotin.

The eluate fractions were pooled and the tag removed by overnight cleavage with 100 μg TEV protease at 4°C. The sample was diluted 3-fold in 20 mM Tris-HCl pH 8.5, 10% Glycerol, 1 mM DTT and then loaded onto a 1 mL HiTrap Q column. Chl1 was eluted with a 20 column-volume gradient from 0.1 -- 0.4 M NaCl in 20 mM Tris-HCl pH 8.5, 0.1 M NaCl, 10% Glycerol, 1 mM DTT. The peak fractions were pooled, diluted with 20 mM Tris-HCl pH 8.5, 10% Glycerol, 1 mM DTT to a conductivity equivalent of 0.1 M NaCl, and loaded onto a 0.24 mL MiniQ column. Chl1 was eluted with a 5 mL gradient from 0.1 -- 0.4 M NaCl. The peak fractions containing Chl1 were pooled, aliquoted and snap frozen.

#### Csm3-Tof1 {#sec4.4.3.3}

Powder was thawed in buffer A / 0.2 M NaCl / protease inhibitors (Roche tablets + homemade cocktail) and the insoluble material removed by centrifugation (235,000 x g, 4°C, 1 h). The soluble extract was supplemented with 2 mM CaCl~2~, 2 mL calmodulin affinity resin was added, and the mixture incubated with rotation at 4°C for 90 min.

The resin was collected and washed extensively with buffer A / 0.2 M NaCl. The washed resin was resuspended in one column volume of buffer A / 0.2 M NaCl and incubated with 200 μg TEV protease for 4 h at 4°C. The flow-through was collected and HIS-tagged TEV protease was depleted with 1 mL Ni-NTA beads (QIAGEN, 30210).

The Csm3-Tof1 sample was then separated on a 24 mL Superose 6 column in buffer A / 0.2 M NaCl. Csm3-Tof1 peak fractions were pooled, dialysed against buffer A / 0.3 M KOAc, snap frozen and stored at −80°C.

#### Dna2 {#sec4.4.3.4}

Powder was thawed in buffer A / 0.2 M KCl / protease inhibitors (Roche tablets + homemade cocktail) and insoluble material removed by centrifugation (235,000 x g, 4°C, 1 h). The soluble extract was supplemented with 2 mM CaCl~2~, 2 mL calmodulin affinity resin was added, and the mixture incubated with rotation at 4°C for 1 h.

The resin was collected and washed extensively with buffer A / 0.2 M KCl. The washed resin was then resuspended in 1 column-volume of buffer A / 0.2 M KCl and incubated with 240 μg TEV protease at room temperature for 1 h. The flow-through was collected and diluted to a conductivity equivalent of 0.1 M KCl with buffer A. The resulting sample was loaded onto 1 mL HiTrap Q column equilibrated in buffer A / 0.1 M KCl. Dna2 was then eluted with a 20 column-volume gradient from 0.1 -- 0.7 M KCl in buffer A.

Dna2 containing fractions were pooled, concentrated and separated on a 24 mL Superdex 200 column in buffer A / 0.3 M KOAc without NP-40. Dna2 containing fractions were then pooled, concentrated, aliquoted and snap frozen.

#### Fen1 {#sec4.4.3.5}

Powder was thawed in buffer C / 0.2 M NaCl / protease inhibitors (Roche tablets + Sigma protease inhibitors + homemade cocktail). Insoluble material was removed by centrifugation (235,000 g, 4°C, 1 h) and the supernatant was mixed with 2.5 mL anti-FLAG M2 affinity gel (Sigma-Aldrich) at 4°C for 90 min.

The resin was collected and washed with buffer C / 0.2 M NaCl. Fen1 was eluted in 1 column volume of buffer C / 0.2 M NaCl / 0.5 mg / ml 3FLAG peptide, then 1 column volume of buffer C / 0.2 M NaCl / 0.25 mg / ml 3FLAG peptide.

The eluate fraction was diluted 2-fold in buffer C then loaded onto a 1ml HiTrap heparin HP column in buffer D / 0.1 M NaCl. Fen1 was eluted with a 20 column-volume gradient from 0.1 -- 1 M NaCl in buffer D. Fen1 containing fractions were pooled, dialysed versus buffer D / 0.3 M KOAc, snap frozen and stored at −80.

#### Mrc1 {#sec4.4.3.6}

Powder was thawed in buffer A / 0.5 M NaCl / protease inhibitors (Roche tablets + homemade cocktail) and insoluble material was removed by centrifugation (235,000 x g, 4°C, 1 h). The soluble extract was mixed with 4 mL anti-FLAG M2 affinity gel (Sigma-Aldrich, A2220) and the mixture incubated with rotation at 4°C for 90 min.

The resin was collected and washed extensively with 120 mL buffer A / 0.5 M NaCl / protease inhibitors, then 20 mL buffer A / 0.5 M NaCl, then 40 mL buffer A / 0.5 M NaCl / 10 mM MgOAc / 1 mM ATP, then 20 mL buffer A / 0.2 M NaCl. Mrc1--5FLAG was eluted in 1 column volume of buffer A / 0.2 M NaCl / 0.5 mg / ml 3FLAG peptide, followed by 2 column volumes of buffer A / 0.2 M NaCl / 0.25 mg / ml 3FLAG peptide.

The eluate was diluted to a conductivity equivalent to 0.1 M NaCl with buffer A. The resulting sample was loaded onto 1 mL HiTrap Q column equilibrated in buffer A / 0.1 M NaCl. Mrc1 was eluted with a 20 column-volume gradient from 0.1 -- 1 M NaCl in buffer A.

Mrc1-containing fractions were pooled and dialysed against buffer A / 40% glycerol / 0.3 M KOAc for 4 h at 4°C. The dialysed sample was recovered, aliquoted and snap frozen.

#### Pif1 (*S. cerevisiae*) {#sec4.4.3.7}

Rosetta *E. coli* cells (Novagen) were transformed with the relevant Pif1 expression vector (see Key Resources Table). The transformant colonies were inoculated into a 250 mL LB / ampicillin (50 μg/ml) / chloramphenicol (35 μg/ml) culture, which was grown overnight at 37°C with shaking at 200 rpm. The following morning, the culture was diluted into 1-2 l of LB / ampicillin (50 μg/ml) / chloramphenicol (35 μg/ml) to a final OD~600~ of 0.15. The culture was left to grow at 37°C until an OD~600~ of 0.6 was reached. Cells were cooled on ice for 30 min, 1 mM IPTG was added to induce expression, and then the cells were incubated overnight at 23°C. The cells were harvested by centrifugation at 5000 rpm for 10 min in a JLA-9.1000 rotor (Beckman).

For lysis, cell pellets were resuspended in 30 mL of buffer E / 0.3 M NaCl / 30 mM imidazole / Roche protease inhibitor tablets. Lysozyme was added to a final concentration of 500 μg/ml and the mixture then left for 20 min on ice. Subsequently, the sample was sonicated for 90 s (15 s on, 30 s off) at 40% on a Branson Digital Sonifier. Insoluble material was removed by centrifugation at 15000 rpm for 30 min in an SS-34 rotor (Sorvall).

The supernatant was subjected to Ni^2+^ affinity purification by incubation with 1 mL packed bead volume of Ni-NTA resin (QIAGEN) for 90 min at 4°C. The beads were recovered in a disposable gravity flow column and washed extensively with buffer E / 0.3 M NaCl / 30 mM imidazole / Roche protease inhibitor tablets. Pif1 was eluted with 5 column volumes of buffer E / 0.3 M NaCl / 0.4 M imidazole.

The eluate was diluted 2-fold in buffer E lacking salt and then loaded onto a 1 mL HiTrap SP FF column pre-equilibrated in buffer E / 0.15 M NaCl. Protein was eluted with a 20 column-volume gradient from 0.15 -- 1 M NaCl. Pif1 containing fractions were pooled and diluted to a conductivity equivalent of 0.15 M NaCl with buffer E lacking salt. The resultant fraction was then loaded onto a 1 mL HiTrap Heparin HP column pre-equilibrated in buffer E / 0.15 M NaCl. Protein was eluted with a 20 column-volume gradient from 0.15 - 1 M NaCl. Pif1 containing fractions were pooled and dialysed against 25 mM HEPES / 40% glycerol / 5 mM MgOAc / 0.3 M KOAc / 1 mM DTT for 4 h at 4°C. The dialysed sample was recovered, aliquoted and snap frozen.

#### BacPif1 {#sec4.4.3.8}

Pif1 from Bacteroides sp 2 1 16 (BacPif1) was purified as for budding yeast Pif1, until the Ni^2+^ affinity purification step. Following elution from Ni-NTA resin, the eluate was diluted 2-fold in buffer E lacking salt and then loaded onto a 1 mL HiTrap Q HP column pre-equilibrated in buffer E / 0.15 M NaCl. Protein was eluted with a 20 column-volume gradient from 0.15 -- 1 M NaCl. BacPif1 containing peak fractions were pooled and dialysed against 25 mM HEPES / 40% glycerol / 5 mM MgOAc / 0.3 M KOAc / 1 mM DTT at 4°C for 4 h. The dialysed sample was recovered, aliquoted and snap frozen in liquid nitrogen.

#### Pol α / primase {#sec4.4.3.9}

Buffer A / 0.4 M NaCl / protease inhibitors (Roche tablets + homemade cocktail) was added to cell powder and the resuspension was centrifuged (235,000 x g, 4°C, 1 h). The soluble extract was supplemented with 2 mM CaCl~2~ and Pol α / primase was purified by calmodulin affinity chromatography using 2 mL calmodulin affinity resin (GE Healthcare, 17052901).

The eluate fractions were pooled and separated on a 24 mL Superdex 200 column in buffer B + 0.4 M KOAc. Pol α / primase peak fractions were pooled, concentrated, aliquoted and snap frozen.

#### Pol δ {#sec4.4.3.10}

Buffer A / 0.2 M NaCl / protease inhibitors (Roche tablets + homemade cocktail) was added to thawed powder and the sample was centrifuged (235,000 x g, 4°C, 1 h). The soluble extract was recovered and supplemented with 2 mM CaCl~2~. At this point, 1.5 mL calmodulin affinity resin was added and the mixture incubated at 4°C for 90 min with rotation.

The resin was collected and washed extensively with buffer A / 0.2 M NaCl / 2 mM CaCl~2~, and Pol δ was then eluted with buffer A / 0.2 M NaCl / 2 mM EDTA / 2 mM EGTA.

The eluate fractions were pooled, concentrated and loaded onto a 24 mL Superdex 200 column in buffer A / 0.3 M KOAc without NP-40. The peak fractions containing Pol δ were pooled, concentrated, aliquoted and snap frozen.

#### RFC {#sec4.4.3.11}

Powder was thawed in buffer A / 0.15 M NaCl / protease inhibitors (Roche tablets + homemade cocktail) and then centrifuged (235,000 x g, 4°C, 1 h). The soluble extract was recovered and supplemented with 2 mM CaCl~2~ and RFC purified by camodulin affinity chromatography using 1 mL resin.

Eluate fractions were pooled and loaded onto a 1 mL HiTrap SP FF column in buffer A / 0.15 M NaCl. RFC was eluted with a 20 column-volume gradient from 0.15 -- 1 M NaCl in buffer A. RFC containing fractions were pooled and dialysed against buffer A / 0.3 M KOAc for 4h at 4°C. The dialysed sample was recovered, concentrated, aliquoted and snap frozen.

#### Rrm3 {#sec4.4.3.12}

The frozen cell powder was resuspended in 3 volumes of buffer F / 0.5 M KCl / protease inhibitors (Roche tablets + Sigma inhibitors + homemade cocktail) and centrifuged (235,000 x g, 4°C, 1 h). Solid ammonium sulfate was added gradually to the soluble extract to 30% final concentration with stirring (10 min, 4°C). The insoluble material was then removed by centrifugation (27,000 x g, 4°C, 20 min) and the supernatant was mixed with 4 mL anti-FLAG M2 affinity gel (Sigma-Aldrich) at 4°C for 30 min.

The resin was collected and washed with 40 column volumes of buffer A / 0.5 M KCl / protease inhibitors, then 10 column volumes of buffer A / 0.5 M KCl / 5 mM MgOAc / 1 mM ATP, then 10 column volumes of buffer A / 0.5 M KCl. At this point, 3FLAG-Rrm3 was eluted in 1 column volume of buffer A / 0.5 M KCl / 0.5 mg / ml 3FLAG peptide, then 2 column volumes of buffer A / 0.5 M KCl / 0.25 mg / ml 3FLAG peptide.

The eluate was dialysed against buffer A / 0.3 M KCl for 3 h at 4°C, then loaded onto a 1 mL HiTrap heparin column equilibrated in buffer A / 0.3 M KCl / 10 mM MgOAc / 1 mM ATP. Rrm3 was eluted with a 15 column-volume gradient from 0.3 -- 1 M KCl in buffer A / 10 mM MgOAc / 1 mM ATP.

Peak fractions containing Rrm3 were pooled and dialysed against buffer A / 40% glycerol / 0.35 M KCl at 4°C for 4 h. The dialysed sample was recovered, aliquoted and snap frozen.

#### Srs2 {#sec4.4.3.13}

Rosetta *E. coli* cells were transformed with pET11d-Srs2 (see [Key Resources Table](#sec4.1){ref-type="sec"}). A 200 mL LB / ampicillin (50 μg/ml) / chloramphenicol (35 μg/ml) culture was inoculated with transformant colonies and grown overnight at 37°C with shaking at 200 rpm. The following morning, the culture was diluted 20-fold into 2 l of LB / ampicillin (50 μg/ml) / chloramphenicol (35 μg/ml) and then left to grow at 37°C until an OD~600~ of 1 was reached. 0.1 mM IPTG was added and Srs2 expression induced overnight at 16°C. Cells were harvested by centrifugation for 10 min in a JLA-9.1000 rotor (Beckman) at 5000 rpm.

For lysis, cell pellets were resuspended in 30 mL of buffer A / 0.6 M KCl / 30 mM imidazole / Roche protease inhibitor tablets. Sonication was performed as described for Pif1. Insoluble material was removed by centrifugation at 15,000 rpm for 30 min in an SS-34 rotor (Sorvall).

The supernatant was subjected to Ni^2+^ affinity purification by incubation with 1 mL packed bead volume of Ni-NTA resin (QIAGEN) for 90 min at 4°C. The beads were recovered in a disposable gravity flow column and washed extensively with buffer A / 0.6 M KCl / 30 mM imidazole / Roche protease inhibitor tablets. Srs2 was eluted with 10 column volumes of buffer A / 0.6 M KCl / 0.4 M imidazole.

The eluate was diluted 4-fold in buffer A lacking salt and then loaded onto a 1 mL HiTrap SP FF column pre-equilibrated in buffer A / 0.15 M KCl. Protein was eluted with a 20 column-volume gradient from 0.15 -- 1 M KCl. Srs2 containing fractions were then pooled and loaded onto a 120 mL Superdex 200 column in buffer A / 0.2 M KCl. Peak fractions were then re-loaded onto a 1 mL HiTrap SP FF and Srs2 was eluted with a 10 column-volume gradient from 0.2 -- 1 M KCl. The Srs2 containing fractions were pooled, concentrated and snap frozen.

#### Top1 {#sec4.4.3.14}

Powder was thawed in buffer A / 0.3 M NaCl / protease inhibitors (Roche tablets + homemade cocktail) and insoluble material removed by centrifugation (235,000 x g, 4°C, 1 h). At this point, 2 mM CaCl~2~ was added to the soluble extract, followed by 2 mL calmodulin affinity resin, and the mixture incubated for 90 min at 4°C.

The resin was collected and washed extensively with buffer A / 0.3 M NaCl. Top1 was eluted in 6 column volumes buffer A / 0.3 M NaCl / 2 mM EDTA / 2 mM EGTA. The Top1-containing fractions were pooled, concentrated and separated on a 24 mL Superdex 200 column in buffer A / 0.4 M KOAc. The peak fractions were pooled, concentrated, aliquoted and snap frozen.

#### Other proteins {#sec4.4.3.15}

Sgs1 and Top3-Rmi1 were a kind gift from Dr. Stephen Kowalczykowski. *E. coli* TopoIV was purchased from Inspiralis (T4001). ORC, Cdc6, Cdt1-Mcm2-7, DDK, S-CDK, Sld3/7, Cdc45, Dpb11, Pol ε, Sld2, GINS, Mcm10, Ctf4, Top2, PCNA, RPA, ISWI, Nap1, Nhp6, FACT and histones were purified by adapting previously established protocols ([@bib16], [@bib26], [@bib38], [@bib50], [@bib78]). A brief purification strategy for each of these proteins is listed in the [Table S3](#mmc1){ref-type="supplementary-material"}.

### DNA templates {#sec4.4.4}

The DNA templates pBS/ARS1WTA (3.2 kb), pCFK1_WT (5.8 kb), pZN3 (9.7 kb) and pRS425 have been described previously ([@bib14], [@bib43], [@bib73], [@bib78]). pVA18 (5.5 kb) is a smaller derivative of the origin-specific plasmid pZN3. The DNA sequence of pVA18 (5589 bp) is provided below:CTGACGCGCCCTGTAGCGGCGCATTAAGCGCGGCGGGTGTGGTGGTTACGCGCAGCGTGACCGCTACACTTGCCAGCGCCCTAGCGCCCGCTCCTTTCGCTTTCTTCCCTTCCTTTCTCGCCACGTTCGCCGTCCTTCAATGAAACATCGTTGGCCACTAATTTGGCCAGTGCAAAGTAGAACAAATCGGCAGCCTCCCAAGAAAGCTCCTTCTTACCCTTTGCCTCAGTCAGTTCTTCAGCTTCTTCCTTGATCTTGGCATCTAACAATGCAGAGTCGTTGAATAGTCTTCTAGTATAAGATTCCTCTGGAGCGTCCTGTAGCCTTTGTTTTAGTAAAGATTCTAGCCCCACCAAACCATGCTTGAATTCACCAAAGCAAGACATGGTCTCCAAGTGGCAAAATCCAACGTTTTCTTGTTCAACGATAAACTTTAAGGCATCCGAATCACAGTCAGTAGAGATTTGTAAAAGCTTTTGGCCATTGCCAGAAGTTTCACCCTTGATCCAGATTTCATTCCTAGAACGAGAATAATAAACGCCACGACCCAATTCGATGGCCTTTGCTATAGATTTCTTCGAAGAATACACCAACCCTAGACAACGCTCATATTGGTCCACAACTAGGGTGGTATATAAACCGTCAGGACGGTCTGTACGTACTTCACCAAGCACTTCTTTGGTCAACATATCCTTGCTTAATTTCTTTATGGACACAATTTTATCTTGCGAGAATTTTTGTTTTACCATGAATTGATTGGAGAAAACACCGTTCTCTTCCACAACAACACGCTCCTTTGGTACATTCAATTGTTCAACCAAGTGTTCGGCTGTTTTAGCATCTTGGCTTGCAATGAACAGAGAAGAAACTCCGTTGTTCAAGAAGGCAATGATTTCATCATCGCTGAATTTACCACTTGGCAAGGACAAAGCCACCAATGGAACTTCTTCCTCTTTGGAGAACTGGAGAATCTCTTCATTACTCAGGCTCGAGCCATCCAAAAGTACCTGACCAACAAGTGAAACGTATTCCTTCTTACTATTCCATGAGGCCAGATCATCAATTAACGGTAGAATCGGCAAAACCATTATTCAGAAAAAAAATTTTGTAAACTATTGTATTACTATTACACAGCGCAGTTGTGCTATGATATTAAAATGTATCCAGAACACACATCGGAGGTGAATATAACGTTCCATATCTATTATATACACAGTATACTACTGTTCATAGTCATATCCTTTTCTTACCTTCTATATCGAATGACTGATAATGCAACGTGAGTCACTGTGCATGGGTTTAGCAATTATTAAACTAATTTACCGGAGTCACTATTAGAGTCAGTTCGACTGCCTAGAAGAACTGCTGGTTGTCAGGATTGTGATGGGGGCATTCTGCTGTATTATGACCCATCGTATCGCAATGCTCACACCACTGTTGTCTTCCTGCCGTGGTATCGACTGGTGCAGGGGGGTCGAAAATTGGTATACGGTACTACTGCACAACAAACTTTGGAAACCAACTTCAATGATCATCATGACTGCAATAAAAGCACTGAGAAACACGAGTTGATAATACCCACCCCATCAAAACCACTAAAGAAAAGGATATAAAGAAGACAAAGTAAAATGTATCAGCATTTACAACATTTGTCACGTTCTAAACCATTGCCGCTTACTCCAAACTCCAAATATAATGGGGAGGCTTGCGTCCAATTAGGGAAGACATATACAGTTATTCAGGATTACGAGCCTAGATTGACAGACGAAATAAGAATCTCGCTGGGTGAAAAAGTTAAAATTCTGGCCACTCATACCGATGGATGGTGTCTGGTAGAAAAGTGTAATACACAAAAGGGTTCTATTCACGTCAGTGTTGACGATAAAAGATACCTCAATGAAGATAGAGGCATTGTGCCTGGTGACTGTCTCCAAGAATACGACTGATGAAAATAATATTGACGTTCGCATTTAATCTATACCTATAATTCTGTACTTATATACTGTTCCTTAATTGAAGATTTCAACATCGTTTTTGATGTAGGTCTTTTCACCTGGAGGTGCGGCTGGGCTACCGAAGACTAATTGAGCTTGTACGGTCCAAGACTCAGGGATTTTGCTTGGCAAAGCAGCTTTTATGTAACCATTGTAGTGTTGTAGGTGACCACCCAGGCCCATTGCCTCCAAGGCAACCCACGAGTTGATTTGAGCGGCACCAGAGGTATGGTCCGCGAAACTAGGGAATGCAGCTGGTACGCTGGGAAGTCAGCCTTTAGCTTTTCAGTTACCTTGTCGTCGGTGAAGAAGATTACAGAACCAAAGGCCTCATCCCTTGCTGAAGCAGGCCTCTTTTGACCGGCAGGGCTTTCTATAGCCTTAGTCACTTCGTCCCAAACTTTTTTGTGAGTTTCACCAGTCAAGATAACAGCGCGATTTGGCTGGGAGTTGAAAGCGGTGGGTGTGGCTCGAATGATGGTTTGGACGACGGATTGGATGTCGTTGATAGTAATTTCACCAGGTGCGGCCGCTTTCAAAGCGTAAATAGTACGACGAGCAGTTAAAGTTTTCAAATAAGTTGCAACAGCAGACATGATATTGGATTGCCGGAATGGCGATATGTTGATCCCGGATACTTCAGTCTACGAAAAAAGTACAAATTATGTGTCAGTTCCTTCAGTATGGTGTCCTTATATACTGTAGTTTGGACAAGGTGCAAATGCCAAGACCCTAGCCCGAAAAGCTCGAGGCACCCCAGGATCTTCCCCTTTACGTAATTTTCACGTAAAACGCCACAGTCCGATTTTTCTAGAATAATCATTAGTAAAAGCGGTATACTGGATTATTGTACGATAACAAGGTAGAGCTTTATTACTAAGCTAAGACGTTCTTACATCAATAGTGCTGTTCGTTATTGACGTCAGGAGAAGGAGCGGGTCTGGTGAATAGTGTAAGCAGTGTTTCTGAACTTTTTCTTCGTCTAAGTCCTTGTAATGTAAGGTAAGAATGCAAGCATCTTGTTTGTAACCCGGGTGTACGTTGACGTTAGTAAGGGGTGTACGTTGACGTTAGTAAGTCACAAACCCAAGCTTAACTTCTTCGTGAGGAAGGAAAGTGTTGTCTCCTACTTTTTTCAAATTTTCGAATTGTATTTATATTTATTTAGTACTTCTTGAGTTTACATATCCTTCGTAAAAATGCAACTTTTGTCGAAAAACACTTCCAAAAAAAAATAATAATGAATTTATGAAGCATACTAACGAGCGAGCACATCGCTGACCTATCATTACTTCATGAGATAAATTAAGATCTCCTCATATGCGAATTTCCTGTTCAGTGATAAACGTTGATTACGTTATTGATAAAAGTCTTTTCTTCTGGCAAGGGGTACCCAGCTTTTGTTCCCTTTAGTGAGGGTTAATTGCGCGCTTGGCGTAATCATGGTCATCGATGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACACAACATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTAAGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGGACAGTATTTGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCTGACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCTCCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAGTAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGACTGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGCTCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAAGTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATCTTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGCAAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTTCAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTGAATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAGTGCCAC

Covalently closed plasmids for *in vitro* replication reactions were purified using alkaline lysis followed by caesium chloride density gradient centrifugation.

For the preparation of linear DNA templates, 4 μg plasmid DNA was incubated with 2 μL restriction enzyme (New England Biolabs) in 1X CutSmart Buffer (New England Biolabs) in a 40 μL final reaction volume. After incubating for 4h at 37°C, the sample was treated with SDS / proteinase K and the DNA purified by phenol / chloroform extraction. The DNA was then precipitated from the aqueous phase with 0.2 M NaCl and 3 volumes 100% ethanol, then left at −20°C overnight. The following morning, the DNA pellet was harvested by centrifugation, washed with 70% ethanol, harvested again, air-dried, and then resuspended in 15-20 μL TE.

### Molecular weight markers {#sec4.4.5}

Standard molecular weight markers were prepared by dephosphorylating 17 μg λ DNA-HindIII Digest (New England Biolabs N3012S) with 10 U Antarctic Phosphatase (New England Biolabs M0289S) in total volume of 40 μL for 1 h at 37°C. The phosphatase was then inactivated by incubation at 80°C for 10 min. Subsequently, 6.8 μg of dephosphorylated DNA was labeled with γ-\[^32^P\]-ATP using 40 units of T4 Polynucleotide Kinase (New England Biolabs M0201S) for 1 h at 37°C, in a total reaction volume of 40 μl. Unincorporated γ-\[^32^P\]-ATP was removed using Illustra MicroSpin G-50 columns (GE Healthcare) and 5 mM EDTA was added to the recovered sample.

For [Figure 1](#fig1){ref-type="fig"}D, end-labeled 3189 bp plasmid was prepared by digesting 4 μg plasmid DNA with 2 μL SmaI (Roche) in 1X CutSmart Buffer (New England Biolabs) in a 40 μL final reaction volume for 2 h at 25°C. The linearized plasmid was then column purified using the High Pure PCR Product Purification Kit (Roche) and then dephosphorylated and end-labeled with γ-\[^32^P\]-ATP, as described for standard molecular weight markers. Other labeled markers in [Figure 1](#fig1){ref-type="fig"}D were generated by PCR amplification using oligonucleotides 7272 -- 7275 (see [Table S2](#mmc1){ref-type="supplementary-material"}) and pTDK13 plasmid template. In each case, 50 μL PCR reactions were assembled in the presence of 33 nM α-\[32P\]-dCTP and the PCR products were purified over Illustra MicroSpin G-50 columns (GE Healthcare).

### *In vitro* replication assays {#sec4.4.6}

Mcm2-7 loading and DDK phosphorylation was performed as follows. First, 5 nM plasmid DNA template, 5-10 nM ORC, 20 nM Cdc6, 40 nM Cdt1/Mcm2-7 and 20 nM DDK were incubated in 25 mM HEPES-KOH (pH 7.6), 100 mM potassium acetate, 0.02% NP-40-S, 0.1 mg / ml BSA, 1 mM DTT, 10 mM Mg(OAc)~2~, 5 mM ATP at 30°C for 10 min.

Subsequently, separate buffer and replication protein mixtures were added sequentially to the Mcm2-7 loading mixture to give a final replication reaction containing 25 mM HEPES-KOH (pH 7.6), 100 mM potassium acetate (unless otherwise indicated), 0.02% NP-40-S, 0.1 mg/ml BSA, 1 mM DTT, 10 mM Mg(OAc)~2~, 2.75 mM ATP, 30 μM dATP-dCTP-dGTP-dTTP, 33 nM α-\[32P\]-dCTP, 400 μM CTP-GTP-UTP, 20 nM S-CDK, 30 nM Dpb11, 8 nM GINS, 40 nM Cdc45, 30 nM Pol ε, 5 nM Mcm10, 5 nM RFC, 20 nM PCNA, 20 nM Top1, 20 nM Top2, 20 nM Pol α−primase, 25 nM Sld3-7, 10 nM Ctf4, 100 nM RPA, 20 nM Csm3-Tof1, 20 nM Mrc1, 50 nM Sld2, 5 nM Pol δ, 10 nM Fen1 and 20 nM Cdc9 (unless otherwise indicated).

Pol δ, Fen1 and Cdc9 were generally omitted from replication reactions including accessory DNA helicases (except in [Figures 6](#fig6){ref-type="fig"}C and 6D and [Figure S4](#mmc1){ref-type="supplementary-material"}A), in order to prevent strand displacement synthesis by Pol δ, which has previously been shown to be enhanced by Pif1-Rrm3 ([@bib51], [@bib57]). The final concentration of potassium acetate was adjusted to 250 mM in those reactions that included Pol δ.

2-5 μL of the Mcm2-7 loading mixture was generally used per sample and this was typically diluted 4-fold in the final reaction. The extra contribution from protein storage buffers to the final reaction was approximately 22 mM chloride and 50-60 mM acetate, and the corresponding potassium counter-ions. Replication reactions were conducted at 30°C for 20 min unless otherwise indicated.

Pif1 and Rrm3 were included at 5 nm and 12.5 nM, respectively, unless otherwise indicated. For [Figure 4](#fig4){ref-type="fig"}C, Sgs1 and Top3-Rmi1 were included at 10 nM. Srs2, Chl1 and Dna2 were included at 20 nM.

RFC, PCNA, Top2, Ctf4, Csm3-Tof1, Mrc1, Pol δ, Fen1 and Cdc9 were omitted from reactions with the 'minimal replisome', as in [Figure S1](#mmc1){ref-type="supplementary-material"}G.

Origin-specific replication reactions were conducted as above, except that Mcm2-7 loading was conducted at 24°C for 10 min and 80 nM S-CDK was then added directly to this reaction at 24°C for 5 min before the replication step.

For pulse-chase experiments, dATP, dTTP, dGTP and dCTP were each added to 600 μM in the chase at the indicated times. For the experiments in [Figures 1](#fig1){ref-type="fig"}F, [3](#fig3){ref-type="fig"}C, [S4](#mmc1){ref-type="supplementary-material"}B, [S5](#mmc1){ref-type="supplementary-material"}A, the dCTP concentration was adjusted to 2.5 μM in the pulse. For the experiments in [Figures 3](#fig3){ref-type="fig"}C and [S4](#mmc1){ref-type="supplementary-material"}B, SmaI (Roche) was added to a final concentration of 0.5 U/μl concomitant with the chase.

Chromatin replication experiments were carried out using a modified version of an existing protocol ([@bib73]). Briefly, for chromatin assembly, ISW1 (30 nM), Nap1 (3 μM) and histone octamers (150 nM) were incubated in chromatin assembly buffer (25 mM HEPES-KOH (pH 7.6), 10 mM Mg(OAc)~2~, 100 mM KOAc, 0.01% NP-40-S, 5% glycerol, 0.1 mg/ml BSA) for 10 min on ice. Creatine phosphate (40 mM), creatine phosphate kinase (100 μg/ml) and ATP (3 mM) were then added and chromatin assembly initiated by the addition of plasmid template (3 nM). Chromatin assembly was performed at 30°C for 1 h, with addition of ORC (10 nM) after 10 min incubation.

Chromatinised plasmids were purified by applying a 40 μL chromatin assembly reaction to a 400 μL Sephacryl S-400 column (prepared in a 0.8 mL Pierce Centrifuge Column (Thermo Scientific 89868)) pre-equilibrated in 25 mM HEPES-KOH (pH 7.6), 100 mM potassium acetate, 0.02% NP-40-S, 1 mM DTT, 10 mM Mg(OAc)~2~, and then centrifuging at 700 x *g* for 2 min. Chromatin replication was performed as for naked DNA templates with the addition of FACT (80 nM) and Nhp6 (400 nM) in the replication step. Pol δ was included at 10 nM in chromatin replication experiments.

For [Figure 4](#fig4){ref-type="fig"}A, reactions were conducted as with the reconstituted system reactions, except that S-phase extract (8 mg / ml) ([@bib50]) was used instead of purified proteins during the replication step.

### Preparation of substrates for helicase assays {#sec4.4.7}

28 pmol of PAGE-purified oligonucleotides purchased from Sigma (see [Table S2](#mmc1){ref-type="supplementary-material"} for oligonucleotide sequences) were first labeled with γ-\[^32^P\]-ATP using 20 U T4 Polynucleotide Kinase (New England Biolabs M0201S) for 1 h at 37°C in a total reaction volume of 20 μL. Unincorporated γ-\[^32^P\]-ATP was then removed using illustra MicroSpin G-50 columns (GE Healthcare).

For annealing, a 3-fold molar excess of labeled oligonucleotide was incubated with 1.3 pmol of M13 ssDNA (New England Biolabs N4040S) in a total reaction volume of 20 μL with heating to 95°C for 10 min in a metal heating block. The metal block was then placed at room temperature and the sample left to cool for 3 h. Free oligonucleotide was removed from the sample by applying a 20 μL annealing reaction to a 400 μL Sephacryl S-400 column (prepared in 0.8 mL Pierce Centrifuge Columns (Thermo Scientific 89868)) pre-equilibrated in TE. The final concentration of the recovered substrate was estimated to be 38 nM. Substrates were stored at 4°C.

### Helicase assays {#sec4.4.8}

Helicase assays (10 μL volume) were carried out using 1 nM M13-based substrate in buffer containing 25 mM HEPES-KOH (pH 7.6), 0.1 mg/ml BSA, 2 mM Mg(OAc)~2~ and 2 mM ATP. Reactions were assembled on ice, equilibrated to room temperature and the respective helicases added to 50 nM final concentration. Reactions were incubated at 30°C for 30 min.

Reactions were stopped by the addition of EDTA (20 mM), SDS (0.4%) and proteinase K (1/25 volumes) and the incubation continued at 37°C for 10 min. The samples were supplemented with Novex Hi-Density TBE Sample Buffer (ThermoFisher Scientific LC6678) and analyzed in 4%--20% Novex TBE Gels (ThermoFisher Scientific EC62252BOX) at 200 V for 30 min in 1X TBE. Gels were mounted onto chromatography paper (GE Healthcare, 3030-861) and exposed to Amersham Hyperfilm ECL (GE Healthcare) at −80°C.

### Catenation assay with Sgs1-Top3-Rmi1 {#sec4.4.9}

The catenation assay in [Figure S3](#mmc1){ref-type="supplementary-material"}A was carried out using a modified version of an existing protocol ([@bib12]). The 3.2 kb plasmid (5 nM) was incubated with Sgs1 (60 nM), Top3-Rmi1 (400 nM) and RPA (100 nM) at 30°C for 30 min in a 10 μL reaction containing 25 mM HEPES-KOH (pH 7.6), 0.1 mg/ml BSA, 1 mM Mg(OAc)~2~, 1 mM ATP, 100 μg / ml creatine phosphate kinase and 40 mM creatine phosphate. The reaction was stopped by addition of EDTA (50 mM), SDS (0.1%) and proteinase K (1 / 100 volume) and the incubation continued at 37°C for 60 min. Reaction products were then separated in a 1% native agarose gel, which was subsequently stained with EtBr (0.5 μg / ml) for 20 min at room temperature.

### DNA preparation for agarose gel electrophoresis {#sec4.4.10}

For all *in vitro* replication experiments, reactions were quenched by addition of EDTA to 25 mM. SDS (0.1%) and proteinase K (1 / 100 volumes) were subsequently added and the incubation continued at 37°C for 30 min. To this was added an equal volume of phenol:chloroform:isoamyl alcohol 25:24:1 (Sigma-Aldrich P2069) saturated with TE (10 mM Tris-HCl pH 8.0, 1 mM EDTA) and the DNA was then extracted. The aqueous phase was buffer exchanged to TE and unincorporated nucleotides were removed with Illustra MicroSpin G-50 columns (GE Healthcare).

For the experiments in [Figures 7](#fig7){ref-type="fig"}B and [S7](#mmc1){ref-type="supplementary-material"}, frozen cell pellets corresponding to 2 × 10^8^ cells were re-suspended in 400 μL lysis buffer (50 mM Tris-HCl pH 8.0, 0.1 M NaCl, 10 mM EDTA, 1% SDS) and the cell wall removed by incubation with 80 units / ml Lyticase (Sigma) and 1% β-mercaptoethanol at 37°C for 5 min. DNA was then extracted with phenol/chloroform/isoamylalcohol (25:24:1) and the aqueous layer collected using phase lock tubes (SLS, 2302800). The DNA was then precipitated with 2 volumes of 100% ethanol and washed with 70% ethanol before being re-solubilized in 120 μL 10 mM Tris pH 8.0.

### Decatenation of replicated plasmids with *E. coli* TopoIV {#sec4.4.11}

For post-reaction treatment with *E. coli* TopoIV ([Figure 6](#fig6){ref-type="fig"}), replication reactions were processed as above and then treated with TopoIV (Inspiralis, T4001) at 37°C for 30 min as per the manufacturer's instructions. The reactions were quenched and the samples prepared for gel analysis as above.

### One-dimensional agarose gel electrophoresis and Southern blotting {#sec4.4.12}

Samples for denaturing agarose gels were supplemented with 20 mM EDTA, and 1/10 volume alkaline loading dye (0.5 M NaOH, 10% sucrose, xylene cyanol) and then left to denature at room temperature for 10 min. For native gels, samples were mixed with 1/6 volume native loading dye (30% glycerol, 0.25% bromophenol blue). For restriction digestion of the replicated products, 8-14 μL of sample was incubated in 1x CutSmart buffer with 0.25 μL restriction enzyme at 37°C for 30 min, except for SmaI that was incubated at 25°C for 30 min.

Samples were analyzed in 0.6 - 0.8% denaturing agarose gels at 21 V overnight in 30 mM NaOH, 2 mM EDTA, or 0.8% native agarose gels at 20 V overnight in 1X TAE. EtBr was included at 0.5 μg/ml for [Figure 6](#fig6){ref-type="fig"}D.

For the experiments in [Figure 7](#fig7){ref-type="fig"}B and [Figure S7](#mmc1){ref-type="supplementary-material"}, the samples were electrophoresed at 0.4 V / cm for 7 days in 0.8% agarose (Megasieve) in 0.5x TBE. Following neutral Southern blotting onto Hybond-N+ membrane (GE Healthcare), the plasmids were detected by hybridization with a *LEU2* DNA probe that also detected the genomic *leu2* locus. Labeling and detection were performed with the 'random prime labeling module' incorporating fluorescein tagged dUTP (Roche, 11585622910). After hybridization and washing, fluorescein tagged dUTP was detected with alkaline phosphatase tagged anti fluorescein Fab fragments (Roche, 000000011426338910), and revealed with CDP-Star (GE Healthcare, GERPN3682). Images were acquired with the ImageQuant 4000 system (GE Healthcare).

### Two-dimensional native-native agarose gel electrophoresis {#sec4.4.13}

The method was adapted from that described previously ([@bib8]). In an analogous experiment to that in [Figure 7](#fig7){ref-type="fig"}B, involving control and *pif1-m2 rrm3Δ* cells containing the plasmid pRS425, DNA equivalent to 4 × 10^7^ cells was prepared from the 40 minute time point. The DNA was then digested with 110 units of SnaB1 enzyme (New England Biolabs R0130M) in 1x 'CutSmart buffer' in a total volume of 50 μL at 37°C for 4 h.

20 μL of the digested volume was then loaded onto a 0.4% native agarose gel which was run 1 V / cm in 1x TBE for 15 h at room temperature. The lanes were then cut out and reset in a second dimension of 1% agarose containing 0.3 μg/ml EtBr and run in 1x TBE containing 0.3 μg/ml EtBr for 8 h at 5 V / cm in the cold room. The resultant gel was then prepared for Southern blotting and non-radioactive hybridization, as described above for one-dimensional gels.

### Gel imaging and presentation {#sec4.4.14}

For *in vitro* replication experiments, native gels were dried directly onto chromatography paper (GE Healthcare, 3030-861). Denaturing gels were fixed by two incubations (20 min, 4°C) in cold 5% trichloroacetic acid and then dried onto chromatography paper. The dried gels were typically exposed to both Amersham Hyperfilm ECL (GE Healthcare) and BAS-MS Imaging Plates (Fujifilm), which were then developed on a Typhoon phosphorimager (GE Healthcare).

Quantification and Statistical Analysis {#sec4.5}
---------------------------------------

For quantification of replication products, gel images generated on a Typhoon phosphorimager were converted to 16-Bit Tiff files using the Linearize GelData plugin in ImageJ (National Institute of Health). Boxes were drawn around each lane and the peaks corresponding to LRIs and full-length products were selected manually from the resultant lane profiles. The 'percentage full-length products' was then calculated, relative to all the replication products in a given lane.

The corresponding experiments were performed the following number of times: [Figure 1](#fig1){ref-type="fig"}C (3x), [Figure 1](#fig1){ref-type="fig"}D (3x), [Figure 1](#fig1){ref-type="fig"}F (2x), [Figure 2](#fig2){ref-type="fig"}A (3x), [Figure 2](#fig2){ref-type="fig"}C (2x), [Figure 2](#fig2){ref-type="fig"}D (2x), [Figure 3](#fig3){ref-type="fig"}B (2x), [Figure 3](#fig3){ref-type="fig"}C (3x), [Figure 4](#fig4){ref-type="fig"}A (2x), [Figure 4](#fig4){ref-type="fig"}C (2x), [Figure 4](#fig4){ref-type="fig"}D (3x), [Figure 4](#fig4){ref-type="fig"}E (3x), [Figure 4](#fig4){ref-type="fig"}F (2x), [Figure 5](#fig5){ref-type="fig"}B (2x), [Figure 5](#fig5){ref-type="fig"}C (3x), [Figure 5](#fig5){ref-type="fig"}D (3x), [Figure 5](#fig5){ref-type="fig"}E (1x), [Figure 5](#fig5){ref-type="fig"}F (1x), [Figure 6](#fig6){ref-type="fig"}A (3x), [Figures 6](#fig6){ref-type="fig"}C and 6D (3x), [Figure 7](#fig7){ref-type="fig"}B (3x), [Figure 7](#fig7){ref-type="fig"}B (2x), [Figure S1](#mmc1){ref-type="supplementary-material"}D (2x), [Figure S1](#mmc1){ref-type="supplementary-material"}E (2x), [Figure S1](#mmc1){ref-type="supplementary-material"}G (2x), [Figure S2](#mmc1){ref-type="supplementary-material"}A (2x), [Figure S2](#mmc1){ref-type="supplementary-material"}B (2x), [Figure S3](#mmc1){ref-type="supplementary-material"}A (1x), [Figures S3](#mmc1){ref-type="supplementary-material"}B and S3C (3x), [Figure S3](#mmc1){ref-type="supplementary-material"}D (1x), [Figure S3](#mmc1){ref-type="supplementary-material"}E (1x), [Figure S3](#mmc1){ref-type="supplementary-material"}F (2x), [Figure S4](#mmc1){ref-type="supplementary-material"}A (2x), [Figure S4](#mmc1){ref-type="supplementary-material"}B (2x), [Figure S5](#mmc1){ref-type="supplementary-material"}A (1x), [Figure S5](#mmc1){ref-type="supplementary-material"}B (1x), [Figure S5](#mmc1){ref-type="supplementary-material"}C (2x), [Figure S6](#mmc1){ref-type="supplementary-material"}A (3x), [Figure S7](#mmc1){ref-type="supplementary-material"}A (3x). The analyses in [Figures 1](#fig1){ref-type="fig"}E, [S1](#mmc1){ref-type="supplementary-material"}F, [S3](#mmc1){ref-type="supplementary-material"}G and S3H formed part of a number of other experiments, and were thus repeated many times.

Supplemental Information {#app2}
========================

Document S1. Figures S1--S7 and Tables S1--S5Document S2. Article plus Supplemental Information

We gratefully acknowledge support from the Wellcome Trust (reference 204678/Z/16/Z for a Sir Henry Wellcome postdoctoral fellowship to T.D.D. and 102943/Z/13/Z for an investigator award to K.P.M.L.), the Medical Research Council (core grants MC_UU_12016/13 to K.P.M.L. and MC_UP_1201/12 to J.T.P.Y.), BBSRC (project grant BB/N007344/1 to J.B.), and the Royal Society (a research fellowship to J.B.). We thank Valentina Aria for plasmid pVA18, John Diffley for strains and for sharing unpublished data, Steve Kowalczykowski for purified Sgs1 and Top3-Rmi1, Lumir Krejci for plasmids and protocols for expression of Srs2, Martin Singleton for providing baculoviruses that express Chl1, Fabrizio Villa for help with insect cell growth and infection, and MRC PPU Reagents and Services (<https://mrcppureagents.dundee.ac.uk>) for support.

Author Contributions {#sec5}
====================

J.B. analyzed plasmid replication in budding yeast cells ([Figures 7](#fig7){ref-type="fig"} and [S7](#mmc1){ref-type="supplementary-material"}), M.A.O.B. constructed and characterized the *pif1-m2 rrm3Δ* strains, and T.D.D. performed all other experiments. J.T.P.Y. supplied the origin-specific plasmids pZN3 and pVA18, reagents for chromatin replication, and invaluable advice and support. T.D.D. and K.P.M.L. designed the project together with J.B. The manuscript was written by T.D.D. and K.P.M.L. with invaluable input from J.B. and J.T.P.Y.

Declaration of Interests {#sec6}
========================

The authors declare no competing interests.

Supplemental Information can be found with this article online at [https://doi.org/10.1016/j.molcel.2019.01.040](10.1016/j.molcel.2019.01.040){#intref0025}.

[^1]: Lead Contact
